By Chad Bray
Danaher, based in Washington, D.C., has launched an offer to acquire all of the outstanding shares of Nobel Biocare Holding in a deal that would value it at about $2.2 billion.
Published: September 15, 2014 at 4:00AM
from NYT Business Day http://ift.tt/1qQ6srH
via IFTTT
from WordPress http://ift.tt/XmBiwz
via IFTTT
No comments:
Post a Comment